US 11866507
Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same
granted A61PA61P35/00
Quick answer
US patent 11866507 (Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same) held by Inhibrx, Inc. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx, Inc.
- Grant date
- Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P35/00